Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
Mon, 20.07.2026
Bio-Gate AG
Ad hoc announcement pursuant to Article 17(1) of Regulation (EU)
No. 596/2014 (Market Abuse Regulation)
Bio-Gate AG Resolves to Conduct a Capital Increase from Authorized Capital and Announces the Terms of the Rights Offering Approved by the Annual General Meeting on June 30, 2026
Nuremberg, July 20, 2026 — The Executive Board of Bio [ … ]
Mon, 20.07.2026
Hamburger Hafen und Logistik AG
Hamburger Hafen und Logistik Aktiengesellschaft
Publication of insider information in accordance with Art. 17 of the Market Abuse Regulation
HHLA lowers expectations for the 2026 financial year
Hamburg, 20 July 2026 | Based on the business development to date and updated estimates for the further development of the 2026 financial year, the Execut [ … ]
Mon, 20.07.2026
IVU Traffic Technologies AG
Ad-hoc release pursuant to Article 17 MAR
IVU Traffic Technologies AG
ISIN DE0007448508
Listing: Frankfurt Stock Exchange in the sub-segment of the regulated market with additional post-admission obligations (Prime Standard)Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014
Ad-hoc | IVU Traffic Technologie [ … ]
Mon, 20.07.2026
Belimo Holding AG
Belimo delivered an outstanding sales performance (+29.6% in local currencies) across all
geographies and achieved a strong profitability (EBIT margin of 22.5%) in the first half of 2026. The
company’s consistent focus on customer value, innovation, quality, and fast lead times, combined
with its unique culture of highly engaged employees, furth [ … ]
Mon, 20.07.2026
PolyPeptide Group
Media Release – ad hoc announcement pursuant to Art. 53 LR
Samsung Biologics announces tender offer to acquire PolyPeptide Group AG for CHF 44.31 per share
Baar, 20 July 2026 – PolyPeptide Group AG (SIX: PPGN), a specialized global CDMO for peptide-based active pharmaceutical ingredients, today announced Samsung Biologics' tender offer to acquire [ … ]
Fri, 17.07.2026
Mikron Holding AG
Ad hoc announcement pursuant to Art. 53 LR:Half-Year Report 2026
Boudry, July 17, 2026, 7.00 a.m. – Mikron (SIX: MIKN) today reports unaudited financial results in the range of the guidance for the year. Net sales of CHF 180.5 million for the first half of 2026 decreased by 5.9% compared with CHF 191.9 million in the same period of the prior year. [ … ]
Fri, 17.07.2026
Rieter AG
{salutation}}
Attached please find our latest media release.
The Semi-Annual Report 2026 as well as media and investor presentation can be found at: media kit
Kind regards,
Relindis Wieser
Head Group Marketing & Communication
Rieter AG . Klosterstrasse 20 . P.O. Box . CH-8406 Winterthur
T +41 52 208 70 45 relindis.wieser@rieter.com . ww [ … ]
Thu, 16.07.2026
Marinomed Biotech AG
Korneuburg, Austria, 16th July 2026 – Marinomed Biotech AG (VSE:MARI) announces the plan to apply for the initiation of a court restructuring proceeding without self-administration. The application is being filed because the court-approved restructuring plan dated November 14, 2024, cannot be fulfilled due to the breakdown of negotiations by Unithe [ … ]
Thu, 16.07.2026
REPLOID Group AG
REPLOID Group AG and PreZero plan joint insect processing and distribution company
The Executive Board of REPLOID Group AG (“REPLOID”) today resolved to enter into a joint venture with PreZero Stiftung & Co. KG (“PreZero”) and is executing the corresponding agreements.
In the new company, named “CIRCULAR ORGANICS REPLOID V+V GMBH & CO. KG [ … ]
Thu, 16.07.2026
Delivery Hero SE
AD-HOC RELEASE
Public disclosure of inside information pursuant to Article 17 para. 1 of the Regulation (EU) No 596/2014 on market abuse (Market Abuse Regulation – MAR)
NOT FOR DISTRIBUTION, PUBLICATION OR FORWARDING, EITHER DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, SOUTH AFRICA, JAPAN OR ANY OTHER [ … ]
